Literature DB >> 20639859

14-3-3gamma mediates Cdc25A proteolysis to block premature mitotic entry after DNA damage.

Kousuke Kasahara1, Hidemasa Goto, Masato Enomoto, Yasuko Tomono, Tohru Kiyono, Masaki Inagaki.   

Abstract

14-3-3 proteins control various cellular processes, including cell cycle progression and DNA damage checkpoint. At the DNA damage checkpoint, some subtypes of 14-3-3 (beta and zeta isoforms in mammalian cells and Rad24 in fission yeast) bind to Ser345-phosphorylated Chk1 and promote its nuclear retention. Here, we report that 14-3-3gamma forms a complex with Chk1 phosphorylated at Ser296, but not at ATR sites (Ser317 and Ser345). Ser296 phosphorylation is catalysed by Chk1 itself after Chk1 phosphorylation by ATR, and then ATR sites are rapidly dephosphorylated on Ser296-phosphorylated Chk1. Although Ser345 phosphorylation is observed at nuclear DNA damage foci, it occurs more diffusely in the nucleus. The replacement of endogenous Chk1 with Chk1 mutated at Ser296 to Ala induces premature mitotic entry after ultraviolet irradiation, suggesting the importance of Ser296 phosphorylation in the DNA damage response. Although Ser296 phosphorylation induces the only marginal change in Chk1 catalytic activity, 14-3-3gamma mediates the interaction between Chk1 and Cdc25A. This ternary complex formation has an essential function in Cdc25A phosphorylation and degradation to block premature mitotic entry after DNA damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639859      PMCID: PMC2924644          DOI: 10.1038/emboj.2010.157

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation.

Authors:  P Chen; C Luo; Y Deng; K Ryan; J Register; S Margosiak; A Tempczyk-Russell; B Nguyen; P Myers; K Lundgren; C C Kan; P M O'Connor
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

Review 2.  The DNA damage response: putting checkpoints in perspective.

Authors:  B B Zhou; S J Elledge
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

3.  Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345.

Authors:  Kecheng Jiang; Elizabeth Pereira; Melissa Maxfield; Beatriz Russell; Dawn Marie Goudelock; Yolanda Sanchez
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

4.  Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase.

Authors:  M S Chen; J Hurov; L S White; T Woodford-Thomas; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 5.  Cdc25A regulation: to destroy or not to destroy--is that the only question?

Authors:  Kristen E Neely; Helen Piwnica-Worms
Journal:  Cell Cycle       Date:  2003 Sep-Oct       Impact factor: 4.534

6.  Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation.

Authors:  A Jeannine Lincoln; Dineli Wickramasinghe; Paula Stein; Richard M Schultz; Mary Ellen Palko; Maria P De Miguel; Lino Tessarollo; Peter J Donovan
Journal:  Nat Genet       Date:  2002-03-25       Impact factor: 38.330

7.  ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.

Authors:  H Zhao; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

8.  C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding.

Authors:  C Y Peng; P R Graves; S Ogg; R S Thoma; M J Byrnes; Z Wu; M T Stephenson; H Piwnica-Worms
Journal:  Cell Growth Differ       Date:  1998-03

9.  Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes.

Authors:  Lee Zou; Stephen J Elledge
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

Review 10.  Chk1 and Chk2 kinases in checkpoint control and cancer.

Authors:  Jiri Bartek; Jiri Lukas
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

View more
  36 in total

1.  CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo.

Authors:  Leena Chaudhuri; Nicole D Vincelette; Brian D Koh; Ryan M Naylor; Karen S Flatten; Kevin L Peterson; Amanda McNally; Ivana Gojo; Judith E Karp; Ruben A Mesa; Lisa O Sproat; James M Bogenberger; Scott H Kaufmann; Raoul Tibes
Journal:  Haematologica       Date:  2013-10-31       Impact factor: 9.941

Review 2.  The role of Cdc25A in the regulation of cell proliferation and apoptosis.

Authors:  Tao Shen; Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2012-07       Impact factor: 2.505

3.  Pim kinases phosphorylate Chk1 and regulate its functions in acute myeloid leukemia.

Authors:  L L Yuan; A S Green; S Bertoli; F Grimal; V Mansat-De Mas; C Dozier; J Tamburini; C Récher; C Didier; S Manenti
Journal:  Leukemia       Date:  2013-06-10       Impact factor: 11.528

4.  Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection.

Authors:  Brandy Verhalen; Joshua L Justice; Michael J Imperiale; Mengxi Jiang
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

Review 5.  The fork and the kinase: a DNA replication tale from a CHK1 perspective.

Authors:  Marina A González Besteiro; Vanesa Gottifredi
Journal:  Mutat Res Rev Mutat Res       Date:  2014-10-22       Impact factor: 5.657

6.  14-3-3Gamma inhibition of MDMX-mediated p21 turnover independent of p53.

Authors:  Jun-Ho Lee; Hua Lu
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

Review 7.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

Review 8.  Checkpoint kinase 1 in DNA damage response and cell cycle regulation.

Authors:  Mallikarjun Patil; Navjotsingh Pabla; Zheng Dong
Journal:  Cell Mol Life Sci       Date:  2013-03-19       Impact factor: 9.261

9.  Structural basis for recruitment of the CHK1 DNA damage kinase by the CLASPIN scaffold protein.

Authors:  Matthew Day; Sarah Parry-Morris; Jack Houghton-Gisby; Antony W Oliver; Laurence H Pearl
Journal:  Structure       Date:  2021-03-30       Impact factor: 5.006

10.  Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection.

Authors:  Mengxi Jiang; Linbo Zhao; Monica Gamez; Michael J Imperiale
Journal:  PLoS Pathog       Date:  2012-08-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.